Stada buyout prescription finally shows results

Bain Capital and Cinven's €5.3bn buyout of German pharmaceuticals maker Stada went through this week, the firm announced on Friday, after a tense build up to Wednesday's midnight deadline, with the 63% shareholder acceptance threshold only just being reached.

  • By Max Bower
  • 18 Aug 2017

Only just over 63% of shares were tendered for the deal, having been counted throughout Thursday and the final result only announced on Friday morning.

Another source close to the situation had confirmed that only around 35% of shares had been tendered by the end of last week, ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 16,074.60 62 6.98%
2 BNP Paribas 14,553.23 79 6.32%
3 Goldman Sachs 13,002.56 50 5.65%
4 HSBC 12,261.48 74 5.32%
5 Deutsche Bank 11,531.87 64 5.01%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 5,442.63 45 7.89%
2 Goldman Sachs 4,801.82 38 6.96%
3 Deutsche Bank 4,751.46 46 6.89%
4 Credit Suisse 4,353.57 48 6.31%
5 Barclays 4,263.74 37 6.18%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 28,018.08 214 10.98%
2 Citi 21,099.90 168 8.27%
3 Bank of America Merrill Lynch 20,960.58 186 8.22%
4 Goldman Sachs 19,294.20 134 7.56%
5 Barclays 17,943.05 119 7.03%